ArticlePloS one2026
Comprehensive Analysis of the AP2/ERF Transcription Factor Family in Schisandra chinensis and Its Implications for secondary metabolism.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The AP2/ERF transcription factor superfamily is integral to plant secondary metabolism; however, its comprehensive genomic characterization in Schisandra chinensis-a medicinal plant esteemed for its dibenzocyclooctadiene (DBCOD) lignans with a wide range of pharmacological properties-has not yet been conducted. In this study, we identified a total of 144 ScAP2/ERF genes from the high-quality, chromosome-level genome of S. chinensis. These genes were categorized into five subfamilies (ERF, DREB, AP2, RAV, and Soloist) through phylogenetic analysis with Arabidopsis thaliana. Conserved motif analysis confirmed the presence of the characteristic AP2 domain in all ScAP2/ERF proteins, with members of the AP2 subfamily containing two AP2 domains and RAV members featuring both AP2 and B3 domains. Chromosomal localization analysis revealed an uneven distribution of these genes across 14 chromosomes, with clusters identified on chromosomes 1, 2, 6, 10, 11, and 13. Cis-acting element analysis demonstrated an enrichment of light-responsive, MeJA-responsive, ABA-responsive, and anaerobic induction elements in the promoters of ScAP2/ERF genes. Synteny analysis identified 26 pairs of segmentally duplicated genes within the S. chinensis genome and 39 orthologous pairs with A. thaliana. Expression profiling across roots, stems, leaves, and fruits revealed distinct tissue-specific expression patterns. Of the 144 identified genes, 122 (84.7%) were detectably expressed in at least one tissue; among them, ten exhibited notably high expression in fruit tissues, suggesting their potential regulatory roles in the accumulation of pharmacologically active compounds in the medicinal fruit. This study represents a comprehensive genome-wide identification of the AP2/ERF family in S. chinensis, thereby establishing a foundational framework for understanding its evolutionary history and functional diversification. Furthermore, it offers candidate genes for subsequent functional validation in the regulation of their potential roles in regulating secondary metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.